Physician
Pediatric Emergency Medicine
Dr. Bert E. Johansson, MD
|
|
Give Review
Bert E. Johansson is an expert in the field of Pediatric Emergency Medicine. He went to medical school at Tulane University School of Medicine. Bert E. Johansson, MD is also a published physician. He has 31 publication published. The most recent publication is: Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
Publications
- Influenza viral neuraminidase: the forgotten antigen.
- Recombinant influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterova...
- A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A.
- An inactivated subvirion influenza A (H5N1) vaccine.
- Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neurami...
- Complementation of recombinant baculoviruses by coinfection with wild-type virus facilitates production in insect larvae of antigenic proteins of hepatitis B virus and...
- Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.
- Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simul...
- Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition.
- Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminida...
- Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection.
- Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition.
- Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection.
- Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.
- Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.
- Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to...
- Identification of PR8 M1 protein in influenza virus high-yield reassortants by M1-specific monoclonal antibodies.
- Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.
- Influenza vaccine strain selection: equivalence of two antigenically distinct haemagglutinin variants of 1989 H3N2 influenza A virus in protection of mice.
- Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants.
- Programmed antigenic stimulation: kinetics of the immune response to challenge infections of mice primed with influenza inactivated whole virus or neuraminidase vaccine.
- Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice.
- Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants.
- Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
- Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
- Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
- Variation in the divalent cation requirements of influenza a virus N2 neuraminidases.
- Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.
- Variation in the divalent cation requirements of influenza A virus N1 neuraminidases.
- Changing perspective on immunization against influenza.
Schools
Tulane University of Louisiana
Doctors Specialties
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
Accepted Insurances
Education
-
New York Presbyterian Hospital -
Tulane University -
Tulane University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Ariel Chairez, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jorge G. Sainz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gilbert Handal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth Contreras, MD |
|
|
Dr. Krishnawari Pant, MD |
|
|
Dr. Erika M. Vazquez, MD
This Doctor is OpenDoctor Recommended.
|